Chitinase, Phytase, Thiolase

The term Chitinase, Phytase, and Thiolase refers to three distinct and unrelated enzyme classes rather than a single therapeutic target or molecular complex. Chitinases are glycosyl hydrolases that catalyze the degradation of chitin; in humans, enzymes like acidic mammalian chitinase (AMCase) and chitotriosidase-1 (CHIT1) are associated with inflammatory responses and fibrotic lung diseases [1]. Phytases are a type of phosphatase responsible for the hydrolysis of phytic acid (phytate), primarily utilized in agricultural biotechnology to improve nutrient absorption in livestock, with limited direct therapeutic application in humans [2]. Thiolases, or acetyl-CoA acetyltransferases, are essential enzymes in the mevalonate pathway and ketone body metabolism, facilitating the reversible Claisen condensation of acetyl-CoA molecules [3]. Because these enzymes belong to different protein families and participate in disparate physiological processes, they do not constitute a unified target for drug development. Consequently, any pharmacological profile would be specific to the individual enzyme rather than the group as a whole [1][2][3]. Sources: [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154455/ [2] https://pubmed.ncbi.nlm.nih.gov/17561687/ [3] https://www.uniprot.org/uniprotkb/P09110/entry

Other names

ChitinasePhytaseThiolaseAcetyl-CoA acetyltransferase

Inhibition of chitinase activity to reduce inflammation; Thiolase and Phytase do not have established clinical drug mechanisms in this context.